Clinical Trials on Nab-paclitaxel

Total 83 results

Hebei Medical University Fourth Hospital
Beijing 302 Hospital; CSPC Ouyi Pharmaceutical Co., Ltd.

Unknown

Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Capecitabine in the Treatment of Advanced Triple-negative Breast Cancer

Triple Negative Breast Cancer | Nab-paclitaxel

China
Hebei Medical University Fourth Hospital
Beijing 302 Hospital; CSPC Ouyi Pharmaceutical Co., Ltd.

Unknown

Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Epirubicin in the Neoadjuvant Therapy for Breast Cancer

Breast Cancer | Triple-negative Breast Cancer | Nab-paclitaxel

China
Wuhan Union Hospital, China

Unknown

Study of Gemcitabine Plus Nab-paclitaxel Versus S1 Plus Nab-paclitaxel in Metastatic Adenocarcinoma of the Pancreas

Pancreatic Cancer | Gemcitabine | Nab-paclitaxel | S1

China
Universitätsklinikum Hamburg-Eppendorf
BARMER; GermanVasc; MDEpiNet Verband Deutschland e.V.

Not yet recruiting

Analysis of Linked Health Insurance Claims and Clinical Registries to Determine Device Surveillance With Paclitaxel-coated Medical Devices (PacliVasc)

Outcome, Fatal | Paclitaxel Adverse Reaction
Centre hospitalier de l'Université de Montréal...

Completed

Comparison of Two Regimens of Dexamethasone in the Prevention of Hypersensitivity Reactions to Paclitaxel, a Pilot Study (DEXEL-RH)

Prevention of Hypersensitivity Reactions to Paclitaxel

Canada
Nestlé

Completed

Method Optimization for the Quantification of the NAD

NAD

Switzerland
Beth Israel Medical Center
St. Luke's-Roosevelt Hospital Center

Completed

Calcium and Magnesium Infusion for the Prevention of Taxane Induced Neuropathy

Paclitaxel-induced Neuropathy

United States
Centre Hospitalier Departemental Vendee

Completed

Appropriation and Impact of the Introduction of Naps During Night Work by Intensive Care Caregiver - One Year Review (MARIENAIE)

Nap

France
Taizhou Hospital

Unknown

Paclitaxol Every 2 Week Versus Paclitaxol Every 1 Week in the Adjuvant Treatment of Breast Cancer (PATEN)

Breast Cancer | Paclitaxel | Cyclophosphamide | Epirubicin
M.D. Anderson Cancer Center

Recruiting

A Phase I/II Study of Intraperitoneal Paclitaxel in Patients With Metastatic Appendiceal Adenocarcinoma

Intraperitoneal Paclitaxel | Metastatic Appendiceal Adenocarcinoma

United States
Charite University, Berlin, Germany
ChromaDex, Inc.

Recruiting

Nicotinamide Riboside Impact on Extracellular Nicotinamide Adenine Dinucleotide (NAD+) (NICE)

NAD

Germany
Cairo University
Samuel Bekhet Moawad; Ahmed Shaker Ragab; Michael Wahib Wadid

Completed

U/S Guided SAB VS U/S Guided SAB With Modified Pectoral Nerve Block in Modified Radical Mastectomy

U/S Guided SAB VS U/S Guided SAB Combined With Modified Pectoral Nerve Block

Egypt
St. Luke's Hospital and Health Network, Pennsylvania

Completed

Use of NAC in Alleviation of Hangover Symptoms

Hangover Symptoms, NAC

United States
Beth Israel Deaconess Medical Center
Boston Scientific Corporation; Medtronic; Philips Healthcare; Bard Peripheral Vascular... and other collaborators

Active, not recruiting

Safety Assessment of Femoropopliteal Endovascular Treatment With PAclitaxel-coated Devices (SAFE-PAD Study) (SAFE-PAD)

Peripheral Arterial Disease | Safety Issues | Paclitaxel Adverse Reaction

United States
iVascular S.L.U.

Recruiting

European All-comers' Multicentric Prospective REGISTRY on LUMINOR© Drug Eluting Balloon in the Superficial Femoral Artery and Popliteal Artery With 5 Years Follow-up. (LUMIFOLLOW)

Peripheral Arterial Disease | Angioplasty | Paclitaxel | Drug-eluting Balloon | Femoral Artery

France
Shanghai Cell Therapy Group Co.,Ltd
Shanghai Mengchao Cancer Hospital

Not yet recruiting

The Exploratory Study on the Baseline Level of NAD+/NADH in Peripheral Blood Samples of Different Gender and Age Groups of Healthy Adults.

NAD+/NADH in Peripheral Blood Monitoring

China
Oregon Health and Science University
Society of Family Planning

Completed

Opioid Analgesia for MAB

Pain | MAB

United States
Mespere Lifesciences Inc.

Completed

Correlation of Measurements From Mespere Venus 1000 System & Echocardiography to Estimate Right Atrial Pressure

Patients Referred to St. Michael's Hospital Echocardiography Lab

Canada
Supplement Formulators, Inc.

Completed

Open-label Study to Assess Increasing Levels of NAD+(Nicotinamide Adenine Dinucleotide)

Increase in Blood Levels of Nicotinamide Adenine Dinucleotide (NAD+)

United States
Hangzhou Cancer Hospital

Completed

CCRT for Esophageal Cancer.

Esophageal Cancer | Paclitaxel | Concurrent Chemoradiotherapy | Oxaliplatin
Ain Shams University

Completed

ABCB1 SNPs as Predictors of PIPN

Breast Cancer | Neuropathy;Peripheral | Paclitaxel Adverse Reaction

Egypt
Lindner Center of HOPE

Terminated

N-acetylcysteine in Bulimia Nervosa

NAC

United States
AstraZeneca

Active, not recruiting

Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Carboplatin and/or Paclitaxel

Advanced Ovarian Cancer | Paclitaxel | Carboplatin | Triple Negative Metastatic Breast Cancer

Belgium, Netherlands, United Kingdom
Seoul St. Mary's Hospital

Recruiting

Intraperitoneal Paclitaxel With XELOX in Gastric Cancer With Peritoneal Metastasis (IPXELOX)

Stomach Neoplasms | Peritoneal Metastases | Paclitaxel

Korea, Republic of
Yale University

Completed

Objective Evaluation of Paclitaxel/Docetaxel-induced Neuropathy in Breast Cancer Patients

Breast Cancer | Chemotherapy Induced Peripheral Neuropathy | Paclitaxel Induced Neuropathy

United States
Stimvia s.r.o.

Completed

Open Label Study to Evaluate the Efficacy of the Home Based Electrical Transcutaneous URIS I in the Treatment of Overactive Bladder (OAB).

Overactive Bladder (OAB) | Failed Any OAB Pharmacotherapy

Czechia
Yonsei University

Recruiting

Fibroblast Growth Factor (FGFs) / Fibroblast Growth Factor Receptor (FGFRs) Genetic as a Second-line Therapy for Recurrent / Progressive Gastric Cancer With INCB054828 and Paclitaxel a Study to Evaluate the Safety and Efficacy of Combination Therapy.

Fibroblast Growth Factors (FGFs)/Fibroblast Growth Factor Receptors (FGFRs) Genetic Aberration Gastric Cancer, INCB054828, Paclitaxel

Korea, Republic of
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Chemoradiotherapy in Unresectable Esophageal Cancer

Esophageal Cancer | Unresectable Malignant Neoplasm | Chemoradiotherapy | Albumin-bound Paxlitaxel

China
Instituto Dante Pazzanese de Cardiologia
Medtronic

Completed

Drug Eluting Balloon Angioplasty Versus Nitinol Stent Implantation in the Superficial Femoral Artery (PAVENST)

Cardiovascular Diseases | Arteriosclerosis | Arterial Occlusive Diseases | Peripheral Arterial Disease | Peripheral Vascular Diseases | Atherosclerosis | Plaque, Atherosclerotic | Critical Limb Ischemia | Paclitaxel

Brazil
Lei Li

Recruiting

Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy: Multi-Center Trial

Chemotherapy | Recurrent Cervical Carcinoma | Immune Checkpoint Inhibitors | Anti-PD-1 Antibody | Persistent Advanced Cervical Carcinoma | Albumin-bound Paclitaxel

China
The University of Texas Health Science Center at...
University of Texas; South Texas Veterans Health Care System

Completed

The Effects of Nicotinamide Adenine Dinucleotide (NAD) on Brain Function and Cognition (NAD)

Mild Cognitive Impairment | NAD

United States
University of Bern

Not yet recruiting

The Efficacy of Tooth Mouse, SFD and NaF in Caries Activity in Root Caries. A Randomized Clinical Trial

Root Caries | NaF | SDF | Tooth Mousse

Switzerland
The First Affiliated Hospital with Nanjing Medical...

Unknown

This Study Was a Prospective, One-arm Open Phase II Clinical Trial. A Systematic Review of the pCR of Apatinib in Combination With the Albumin Paclitaxel and Carboplatin Regimens for the Neoadjuvant Therapy of Triple-negative Breast Cancer, as Well as the Safety of Treatment

Systematic Review of the pCR Rate of Apatinib Combined With Albumin Paclitaxel and Carboplatin Regimen for Neoadjuvant Therapy of Triple-negative Breast Cancer

China
Meir Medical Center

Unknown

Detection of PCOS by Sensors Array

Metabolic State, Breath Analysis, NA-Nose
Qilu Pharmaceutical Co., Ltd.

Not yet recruiting

A Multicenter, Randomized, Double-blind Phase II Trial to Evaluate GM1 Prevention of Peripheral Neuropathy in Patients With Breast Cancer

To Evaluate the Effectiveness of GM1 in the Prevention of Albumin-paclitaxel Therapy Induced Peripheral Neuropathy in Breast Cancer Patients
Seoul National University Bundang Hospital
Boryung Pharmaceutical Co., Ltd; B. Braun Korea Co., Ltd.

Completed

Intraperitoneal Paclitaxel Plus Systemic mFOLFOX6 (IPLUS)

Peritoneal Carcinomatosis | Gastric Cancer Stage IV | Intraperitoneal Paclitaxel | mFOLFOX6

Korea, Republic of
Centre Hospitalier Universitaire, Amiens

Not yet recruiting

Intratumoral Gemcitabine, Paclitaxel, Carboplatine and Intravenous Nivolumab for Locally Recurrence of Head and Neck Cancers (NIVOCHIMLOC)

Squamous Cell Carcinoma of the Head and Neck | Paclitaxel | Nivolumab | Carboplatin

France
Trustees of Dartmouth College
Patient-Centered Outcomes Research Institute

Completed

MOms in REcovery (MORE) Study: Defining Optimal Care (MORE)

Opioid-Related Disorders | Substance Use Disorders | NAS

United States
Al-Azhar University

Active, not recruiting

A Comparison of Two Protocol for Maxillary Molar Intrusion Buccal Miniscrew and TPA Versus Vertical Holding Appliance

Dental Intrusion | Mandibular Rotation | ANB , SNA, SNB | Openbite Teeth | Teeth and Gum | Dental

Egypt
LifeNet Health

Withdrawn

Devitalized Non-valved Pulmonary Artery Allograft Implant for the Repair of Congenital Cardiac Abnormalities

NA-Study Withdrawn
Astellas Pharma Singapore Pte. Ltd.

Completed

A Study on Anticholinergic Use: Attribution of Overactive Bladder (OAB) Medications to the Anticholinergic Burden

Overactive Bladder (OAB)

Korea, Republic of, Australia
Jeil Pharmaceutical Co., Ltd.

Completed

The Safety and PK Characteristics of the Co-administration of JLP-2002 and Comparator in Healthy Volunteers

Overactive Bladder(OAB)

Korea, Republic of
Region Skane
Lund University

Terminated

Probiotics for Reduction of Infections With Clostridium Difficile in Critically Ill Patients (ProbiEnt)

Clostridium Difficile Colonisation | Impact of Enteral Probiotics on Certain Lab Parameters

Sweden
Novartis
Procter and Gamble

Completed

Patient's Perception of Treatment Outcome With Darifenacin by Patients With Overactive Bladder

Overactive Bladder (OAB)

United States
Pfizer

Completed

Drug Use Investigation for Toviaz

Overactive Bladder (OAB)
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Detrol LA In Men With Overactive Bladder.

Overactive Bladder (OAB)

United States, Canada, Germany, Korea, Republic of, Spain, Turkey, Taiwan, Italy, Slovakia, Denmark, South Africa, United Kingdom, Mexico, Sweden, Norway
Medstar Health Research Institute
Columbia University; University of Michigan; University of New Mexico; Methodist...

Terminated

PTNS vs Botox of Refractory OAB (TROOP)

Overactive Bladder (OAB)

United States
Astellas Pharma Global Development, Inc.

Completed

A Study to Evaluate Tolerability and Participants Preference Between Mirabegron and Tolterodine Extended Release (ER) in Participants With Overactive Bladder (OAB) (PREFER)

Overactive Bladder (OAB)

United States, Canada
Astellas Pharma Singapore Pte. Ltd.

Completed

Treatment Persistence Among Patients With Overactive Bladder: A Retrospective Secondary Data Analysis in Asia Oceania

Overactive Bladder (OAB)

Korea, Republic of, Australia
Assiut University

Not yet recruiting

Glycemic Gap Versus Admission Plasma Glucose Level As Predictors of ICU Out Comes in Type 2 Diabetic Patients With Acute Heart Failure

Assess the Relation Between Glycemic Gab and Adverse Clinical Outcomes in Diabetic Patients Who Hospitalized With Heart Failure

Clinical Trials on Nab-paclitaxel

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saudi Arabia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations